Shenmai Injection Improves Hypertensive Heart Failure by Inhibiting Myocardial Fibrosis via TGF-β 1/Smad Pathway Regulation
Crossref DOI link: https://doi.org/10.1007/s11655-022-2899-y
Published Online: 2022-07-15
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Si-yuan
Zhou, Yao
Zhong, Sen-jie
Yang, Meng
Huang, Shu-min
Li, Lin
Li, Xin-chun
Hu, Zhi-xi
Text and Data Mining valid from 2022-07-15
Version of Record valid from 2022-07-15
Article History
Accepted: 12 January 2022
First Online: 15 July 2022